Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Google will spend $85 billion on artificial-intelligence projects this year. Its rivals are likely to spend more.

Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.

The International Chamber of Commerce (ICC), the world business organization representing more than 4.5-million-member ...

SmallCap stocks can often be overlooked by institutional investors, yet they offer outsized return potential for those ...

While FDA Commissioner Marty Makary emphasizes learning and humility, the FDA has systematically removed the very experience ...

Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal ...

Paul Walsh, founder and managing partner of Walsh Barnes, is winding down his practice after 35 years to launch his own ...

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its ...

Overview of Breast Cancer Therapeutics MarketThe Global Breast Cancer Therapeutics Market is valued at USD 33.83 Billion in ...

Sarepta Therapeutics’ share price has fallen again following the death of a third patient dosed with its gene therapy treatment.

Yale SOM leadership expert Jeffrey Sonnenfeld and co-author Steven Tian argue that Cook’s unmatched track record makes him uniquely positioned to steer the company into its next phase of innovation ...